U.S. Basic Materials Stock News

EMCOR Group (EME) has quietly pulled back over the past month after a strong year to date, giving investors a chance to reassess whether the recent dip lines up with its steady earnings growth. See our latest analysis for EMCOR Group. While the 30 day share price return of minus 9.1 percent shows some momentum cooling after a strong run, EMCOR’s year to date share price gain and standout multi year total shareholder returns still point to a structurally strong story rather than a broken...

Customers Bancorp (CUBI) just delivered an earnings release that landed well with the market, with revenue jumping sharply year on year and topping expectations, and investors are now weighing how much upside is left in the stock. See our latest analysis for Customers Bancorp. The latest results add fuel to a rally that was already in motion, with a year to date share price return of nearly 50 percent and a three year total shareholder return above 140 percent. This points to building...

Affirm recently announced a partnership with fashion retailer Pacsun, allowing shoppers to use its buy-now-pay-later plans and access a 10% “AFFIRM” promo on Holiday Gift Guide purchases through December 18, 2025. This collaboration adds another recognizable retail brand to Affirm’s nearly 420,000-merchant network, underscoring how installment payments are becoming embedded in mainstream seasonal shopping. We’ll now look at how this Pacsun tie-up, especially its holiday-focused BNPL offer,...

Trade Desk (TTD) has been grinding lower, with the stock down about 67% year to date and roughly 26% in the past 3 months, despite double digit revenue and profit growth. See our latest analysis for Trade Desk. That slide has wiped out much of the prior multi year gains, with the 1 year total shareholder return now around negative 72 percent and even the 5 year total shareholder return sitting near negative 58 percent. This is a sign that sentiment and momentum have clearly faded even as...

If you are wondering whether Dynavax Technologies is quietly turning into a value opportunity or just another biotech rollercoaster, you are in the right place. The stock has slipped about 4% over the last week but is still up roughly 9.2% over the past month, even though it remains down around 15.0% year to date and 14.5% over the last year, after a strong 140.0% gain over five years. Recent attention has centered on Dynavax's expanding role in vaccine adjuvants and partnerships that aim to...

If you are wondering whether Nutanix at around $47 a share is a bargain in disguise or a value trap waiting to happen, this breakdown is for you. The stock has slid about 33.3% over the last month and is down 22.6% year to date, yet it is still sitting on gains of roughly 57.4% over 3 years and 59.6% over 5 years. That kind of whiplash in returns has coincided with shifting sentiment around high growth software names, as investors rotate between riskier cloud stories and more predictable...

Pagaya Technologies (PGY) has been on a wild ride this year, with the stock soaring more than 140% year to date but sliding roughly 36% over the past 3 months, leaving investors reassessing expectations. See our latest analysis for Pagaya Technologies. That kind of split personality, with a 147.35% year to date share price return but a steep 36.07% three month share price pullback, suggests early year enthusiasm is cooling as investors recut expectations around growth, risk and what they are...

TETRA Technologies recently announced it signed a term sheet to form a joint venture with Magrathea Metals to integrate electrolytic magnesium production into its Evergreen Project in Southwest Arkansas, which is expected to produce 75 million pounds of bromine annually and recover other critical minerals like lithium and magnesium. This collaboration aims to help rebuild the U.S. magnesium metal defense industrial base using brine-based resources, potentially broadening TETRA’s role in...

Restaurant Brands International (QSR) has quietly outperformed the broader market over the past 3 months, and that move is making investors take a closer look at what is driving this momentum. See our latest analysis for Restaurant Brands International. Zooming out, that 15.9% 3 month share price return sits on top of a steadier 9.8% year to date share price gain and a more modest 5.0% one year total shareholder return. Together, these moves suggest momentum is quietly building rather than...

Super Micro Computer (SMCI) has been on many watchlists after it cut Q1 FY2026 revenue guidance due to delayed AI deliveries, yet reiterated an aggressive full-year growth outlook tied to AI servers. See our latest analysis for Super Micro Computer. The guidance cut has capped what was already a volatile stretch, with a 1 month share price return of minus 28.95 percent but a still positive year to date share price return of 12.08 percent. A 3 year total shareholder return above 290 percent...

If you are wondering whether Dutch Bros at around $61 a share is a caffeine fueled bargain or just pricey buzz, this article is for you. We are going to unpack what the current market price really implies about its future. The stock has quietly kept the momentum going, up about 5% over the last week, 12.3% over the past month, and roughly 12.9% over the last year, compounding into an 87.2% gain over three years. Behind those moves, Dutch Bros has been steadily expanding its store footprint...

Bank of N.T. Butterfield & Son (NYSE:NTB) is in the spotlight after management ramped up share buybacks while Wells Fargo cut its rating, highlighting a tension between internal confidence and macro driven caution. See our latest analysis for Bank of N.T. Butterfield & Son. Those buybacks, alongside the recent Wells Fargo downgrade, come after a strong run. The share price is at $48.28 with a robust year to date share price return of 32.82 percent and a 1 year total shareholder return of...

In late November 2025, SCTbio and Fortrea Holdings announced a collaboration designed to align clinical trial logistics with GMP manufacturing readiness for cell and gene therapies, aiming to shorten development timelines and improve cost-efficiency across the full development lifecycle. This model of closer coordination between a CRO and a CDMO offers a differentiated way to support the more than 4,400 advanced therapies currently in development, potentially reducing program risk for...

Toll Brothers has recently expanded its luxury footprint with new and upcoming communities across Washington, Florida, Nevada, Georgia, and North Carolina, featuring high-end single-family homes, townhomes, and 55+ active-adult offerings priced from the mid-US$500,000s to the mid-US$900,000s. These openings and new phases highlight the company’s focus on amenity-rich, design-customizable communities in supply-constrained, higher-income markets from Seattle’s suburbs to historic St...

Organon & Co. recently presented at the Piper Sandler 37th Annual Healthcare Conference in New York, with Interim CEO Joe Morrissey and CFO Matthew Walsh outlining the company’s current positioning and outlook. This update comes as Organon balances renewed investor interest and a recent rebound in search activity with ongoing pressure from multi‑year declines in revenue, earnings, and cash flow margins. Against this backdrop of rising attention and mixed fundamentals, we’ll examine how...

Peoples Bancorp (PEBO) just turned heads with a stronger quarter, posting revenue growth, higher net income, and cleaner credit metrics, all while backing a dividend yield above 5% that has been increasing over time. See our latest analysis for Peoples Bancorp. That stronger quarter seems to be nudging sentiment in the right direction, with a roughly 7% 1 month share price return off the back of better credit quality, even as the 1 year total shareholder return of about negative 8% reminds...

Wondering if Marriott International at around $306 a share is still a smart buy or if most of the upside is already priced in? You are not alone. This stock divides opinion among value focused investors. Over the last month the stock has climbed 12.6%, adding to a strong 3 year gain of 96.7% and a 5 year gain of 141.3%, while the 1 year return of 5.9% and 7 day move of 0.7% suggest momentum has cooled a little. Recently, investors have been digesting a mix of travel industry updates, from...

CureVac (NasdaqGM:CVAC) has just been dropped from the NASDAQ Biotechnology Index, a mechanical change that can still matter for investors as index tracking funds trim positions and liquidity dynamics start to shift. See our latest analysis for CureVac. That index removal lands after a busy stretch for CureVac, including new board appointments and mixed earnings. It also comes at a time when the share price has climbed sharply year to date, although longer term total shareholder returns still...

The 14% workforce reduction at Lattice Semiconductor (LSCC) has investors asking whether management is tightening the belt from a position of strength or quietly bracing for a slowdown after in line third quarter results and active insider trading. See our latest analysis for Lattice Semiconductor. Against that backdrop, Lattice’s 1 day share price return of 5.21 percent and roughly 34 percent year to date share price gain suggest investors still see long term growth potential despite...

Acadian Asset Management Inc. has now completed the redemption of all US$275,000,000 of its 4.800% Senior Notes due July 27, 2026, funded by a previously arranged US$200,000,000 term loan and cash on hand. By pairing this early bond redemption with a new three-year term loan and a US$175,000,000 revolving credit facility maturing in 2028, the firm is reshaping its funding mix and financial flexibility. Next, we’ll examine how this early bond redemption and expanded revolving credit capacity...

Eos Energy Enterprises (EOSE) just raised about $458 million through a follow on equity offering of roughly 35.9 million common shares at $12.78, a move that immediately puts dilution and growth plans in focus. See our latest analysis for Eos Energy Enterprises. The fresh capital raise lands after a volatile run, with the latest share price at $13.55, a 90 day share price return of 84.6 percent and a 1 year total shareholder return of 356.23 percent, signaling strong but risk aware...

Global Ship Lease (NYSE:GSL) is leaning into its fleet renewal strategy by agreeing to buy three Korean built 8,600 TEU containerships with ECO upgrades and long term charters attached for $90 million. See our latest analysis for Global Ship Lease. That strategy is landing against a strong backdrop, with the share price up 14.4 percent over the past month and delivering a 73.6 percent total shareholder return over the last year. This suggests momentum is building as earnings and fleet moves...

IDEXX Laboratories recently reported its third-quarter 2025 results, posting earnings per share of $3.40, a 21.4% increase year over year, and raised its full-year 2025 outlook for both revenue and earnings growth. The strong performance was powered by robust expansion in the Companion Animal Group and Livestock, Poultry and Dairy segments, highlighting the growing importance of recurring diagnostics and testing services in IDEXX’s global portfolio. With IDEXX lifting full-year guidance on...

ICF International (ICFI) caught traders attention after a Canaccord Genuity analyst upgrade pushed the stock up about 4%, as investors latched onto renewed growth expectations and managements steady guidance. See our latest analysis for ICF International. The move comes after a tough stretch, with the share price down sharply on a year to date basis and the 1 year total shareholder return also negative. However, the recent 7 day and 30 day share price gains suggest momentum may be stabilizing...